We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Association Between Positive iNOS mRNA Expression and Recurrence-free Survival Among Patients with Non-muscle-invasive Bladder Cancer
- Authors
Lu, Chih-Ming; Chiu, Allen W.; Huang, Yu-Lun; Lee, Ying-Huei; Ko, Ying-Chin
- Abstract
Abstract: Objective: Nitric oxide synthase is the key enzyme of the conversion of L-arginine to L-citrulline and nitric oxide. We conducted a study to investigate the association between positive inducible nitric oxide synthase (iNOS) mRNA expression and recurrence of bladder cancer. Materials and Methods: Seventy-one patients with primary non-muscleinvasive bladder cancer were enrolled in this study. Tumor tissues were harvested during transurethral resection of bladder tumors. All operations were performed at the same hospital. Recurrence-free patients were followed up for at least 1 year unless tumors recurred during that time. The median intervals of follow-up were 34 months in the recurrence-free group and 12 months in the recurrence group. iNOS mRNA was detected using the RT-PCR-based method. Results: Bladder cancer patients with positive iNOS mRNA expression had a higher recurrence risk (18.7%vs. 2.6%; p = 0.04). After adjusting for other risk factors, a statistical significance remained (p = 0.04; hazards ratio = 13.27; 95% CI = 1.07–164.36). The patients also had reduced recurrence-free survival (p = 0.019). Conclusion: The positive expression of iNOS mRNA may be a useful prognostic indicator of bladder cancer.
- Subjects
BLADDER diseases; MESSENGER RNA; BLADDER cancer; NITRIC-oxide synthases; CANCER relapse; ENZYMES; POLYMERASE chain reaction; PATIENTS
- Publication
Tzu Chi Medical Journal, 2008, Vol 20, Issue 2, p119
- ISSN
1016-3190
- Publication type
Article
- DOI
10.1016/S1016-3190(08)60021-X